GrafixPL: payments to doctors
Payments that named GrafixPL as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.5M
- Providers
- 4,124
- Transactions
- 10,131
- Average per transaction
- $153
The per-transaction average — $153 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,124 providers the average total is $375, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Smith+Nephew | $893,812 | 57.7% |
| Osiris Therapeutics Inc. | $654,352 | 42.3% |